Directory

>

Sandy Geeganage

avatar

Sandy Geeganage

Vice President - Drug Discovery | Prelude Therapeutics

Wilmington, Delaware, United States

View contact details (it's free)

Sandy Geeganage

Summary

Sandy Geeganage is an accomplished Vice President of Drug Discovery with over 24 years of leadership experience in the pharmaceutical and biotechnology sectors. He has a robust background in oncology drug discovery, specializing in areas such as small molecules, PROTACs, and immuno-oncology combinations. Sandy's expertise spans various aspects of drug development, including translational research and regulatory filings. He has a proven track record of managing global collaborations between academia and contract research organizations. Sandy holds a Ph.D. in Biochemistry from the University of Wisconsin-Madison and has contributed significantly to the scientific community through numerous publications in prestigious journals. His strategic vision and innovative approach have positioned him as a key player in advancing cancer therapeutics. Sandy is passionate about leveraging his extensive knowledge to drive breakthroughs in drug discovery and development.

General

Specialist

Technical Background

Leadership Experience

Long-Term Tenure

Professional interests

Emerging Technologies

Leadership Development

Innovation

Organisational experience

Corporate Experience

Sandy Geeganage

Work Experience

company logo

Vice President - Drug Discovery at

Prelude Therapeutics

November 2021 - Present

company logo

Executive Director - Target Discovery at

Incyte

May 2020 - November 2021

company logo

Research Fellow - Oncology Discovery at

Eli Lilly and Company

October 2016 - May 2020

company logo

Group Leader, Cancer Signaling and Metabolism at

Eli Lilly and Company

December 2009 - May 2020

company logo

Senior Research Advisor - Oncology Discovery at

Eli Lilly and Company

November 2010 - September 2016

company logo

Research Advisor - Oncology Discovery at

Eli Lilly and Company

November 2008 - October 2010

company logo

Principal Research Scientist - Oncology Discovery at

Eli Lilly and Company

November 2005 - October 2008

company logo

Senior Research Scientist - Oncology Discovery at

Eli Lilly and Company

November 2004 - October 2005

company logo

Research Scientist - Oncology Discovery at

Eli Lilly and Company

November 2000 - October 2004

company logo

Postdoctoral Research Fellow at

University of Wisconsin-Madison

July 1999 - November 2000

company logo

Graduate Student at

University of Wisconsin-Madison

January 1994 - January 1999

Logos provided by Logo.dev

Sandy Geeganage

Education

University of Wisconsin-Madison, Phd

January 1994 - January 1999

The University of the South, B.S.

January 1990 - January 1994

Royal College

January 1975 - January 1987

Frequently Asked Questions about Sandy Geeganage

What is Sandy Geeganage email address?

Sandy Geeganage's primary email address is **********@preludetx.com. To view the full verified email and additional contact details, sign up for free with Muraena.

What company does Sandy Geeganage work for?

Sandy Geeganage is a Vice President - Drug Discovery at Prelude Therapeutics, a company specializing in Commercial physical research.

Where Sandy Geeganage graduated from?

Sandy Geeganage holds a degree in Biochemistry from University of Wisconsin-Madison.

How can I directly contact Sandy Geeganage?

To contact Sandy Geeganage directly, you can use the email address **********@preludetx.com. Complete contact information is available upon registration with Muraena.

Who is Sandy Geeganage?

Sandy Geeganage is an accomplished Vice President of Drug Discovery with over 24 years of leadership experience in the pharmaceutical and biotechnology sectors. He has a robust background in oncology drug discovery, specializing in areas such as small molecules, PROTACs, and immuno-oncology combinations. Sandy's expertise spans various aspects of drug development, including translational research and regulatory filings. He has a proven track record of managing global collaborations between academia and contract research organizations. Sandy holds a Ph.D. in Biochemistry from the University of Wisconsin-Madison and has contributed significantly to the scientific community through numerous publications in prestigious journals. His strategic vision and innovative approach have positioned him as a key player in advancing cancer therapeutics. Sandy is passionate about leveraging his extensive knowledge to drive breakthroughs in drug discovery and development.

Sandy`s contact details

mail

**********@preludetx.com

Colleagues

avatar
Peggy Scherle

Chief Scientific Officer

Andrew Combs

Chief Chemistry Officer

avatar
Tim Mueller

Vice President EHS, Lab Operations, & Facilities

avatar
Kris Vaddi

Chief Executive Officer and Founder

avatar
Michele Porreca

Chief People Officer

avatar
Murty Mangena

Executive Director, Technical Operations

avatar
Lisa Carson

Vice President, Head of Finance & Controller

Sang Hyun Lee

Vice President of Biology

avatar
Naveen Babbar

Senior Vice President, Translation Medicine

avatar
Srikumar Sahasranaman

SVP, Quantitative Clinical Pharmacology

View Contact details (it's free)
Request Profile Removal